Pathologic clonal cytotoxic T-cell responses: nonrandom nature of the T-cell-receptor restriction in large granular lymphocyte leukemia

被引:94
作者
Wlodarski, MW
O'Keefe, C
Howe, EC
Risitano, AM
Rodriguez, A
Warshawsky, I
Loughran, TP
Maciejewski, JP
机构
[1] Cleveland Clin Fdn, Taussig Canc Ctr, Expt Hematol & Hematopoiesis Sect, Cleveland, OH 44195 USA
[2] Cleveland Clin Fdn, Dept Clin Pathol, Cleveland, OH 44195 USA
[3] Charite, Inst Med Immunol, Berlin, Germany
[4] Penn State Canc Inst, Hershey, PA USA
[5] NHLBI, Hematol Branch, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1182/blood-2004-10-4045
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
T-cell large granular lymphocyte (T-LGL) leukemia is a clonal lymphoproliferation of cytotoxic T cells (CTLs) associated with cytopenias. T-LGL proliferation seems to be triggered/sustained by antigenic drive; it is likely that hematopoietic progenitors are the targets in this process. The antigen-specific portion of the T-cell receptor (TCR), the variable beta (VB)-chain complementarity-determining region 3 (CDR3), can serve as a molecular signature (clonotype) of a T-cell clone. We hypothesized that clonal CTL proliferation develops not randomly but in the context of an autoimmune response. We identified the clonotypic sequence of T-LGL clones in 60 patients, including 56 with known T-LGL and 4 with unspecified neutropenia. Our method also allowed for the measurement of clonal frequencies; a decrease in or loss of the pathogenic clonotype and restoration of the TCR repertoire was found after hematologic remission. We identified 2 patients with identical immunodominant CDR3 sequence. Moreover, we found similarity between multiple immunodominant clonotypes and codominant as well as a nonexpanded, "supporting" clonotypes. The data suggest a nonrandom clonal selection in T-LGL, possibly driven by a common antigen. In contrast, the physiologic clonal CTL repertoire is highly diverse and we were not able to detect any significant clonal sharing in 26 healthy controls.
引用
收藏
页码:2769 / 2780
页数:12
相关论文
共 84 条
[61]   Molecular analysis of TCR clonotypes in LGL: A clonal model for polyclonal responses [J].
O'Keefe, CL ;
Plasilova, M ;
Wlodarski, M ;
Risitano, AM ;
Rodriguez, AR ;
Howe, E ;
Young, NS ;
Hsi, E ;
Maciejewski, JP .
JOURNAL OF IMMUNOLOGY, 2004, 172 (03) :1960-1969
[62]   EXPRESSION OF 2 T-CELL RECEPTOR-ALPHA CHAINS - DUAL RECEPTOR T-CELLS [J].
PADOVAN, E ;
CASORATI, G ;
DELLABONA, P ;
MEYER, S ;
BROCKHAUS, M ;
LANZAVECCHIA, A .
SCIENCE, 1993, 262 (5132) :422-424
[63]   T-CELL REPERTOIRE DIVERSITY AND CLONAL EXPANSIONS IN NORMAL AND CLINICAL-SAMPLES [J].
PANNETIER, C ;
EVEN, J ;
KOURILSKY, P .
IMMUNOLOGY TODAY, 1995, 16 (04) :176-181
[64]   Characterization of human cytomegalovirus peptide-specific CD8+ T-cell repertoire diversity following in vitro restimulation by antigen-pulsed dendritic cells [J].
Peggs, K ;
Verfuerth, S ;
Pizzey, A ;
Ainsworth, J ;
Moss, P ;
Mackinnon, S .
BLOOD, 2002, 99 (01) :213-223
[65]  
Plasilova Magdalena, 2003, Hematology, V8, P173, DOI 10.1080/1024533031000107505
[66]   In-vivo dominant immune responses in aplastic anaemia:: molecular tracking of putatively pathogenetic T-cell clones by TCR β-CDR3 sequencing [J].
Risitano, AM ;
Maciejewski, JP ;
Green, S ;
Plasilova, M ;
Zeng, WH ;
Young, NS .
LANCET, 2004, 364 (9431) :355-364
[67]   T-cell large granular lymphocyte leukemia and related disorders [J].
Rose, MG ;
Berliner, N .
ONCOLOGIST, 2004, 9 (03) :247-258
[68]  
Semenzato G, 1997, BLOOD, V89, P256
[69]   T-CELL RECEPTOR (TCR) STRUCTURE OF AUTOLOGOUS MELANOMA REACTIVE CYTOTOXIC T-LYMPHOCYTE (CTL) CLONES - TUMOR-INFILTRATING LYMPHOCYTES OVEREXPRESS IN-VIVO THE TCR BETA-CHAIN SEQUENCE USED BY AN HLA-A2-RESTRICTED AND MELANOCYTE-LINEAGE SPECIFIC CTL CLONE [J].
SENSI, M ;
SALVI, S ;
CASTELLI, C ;
MACCALLI, C ;
MAZZOCCHI, A ;
MORTARINI, R ;
NICOLINI, G ;
HERLYN, M ;
PARMIANI, G ;
ANICHINI, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (04) :1231-1246
[70]   A functional link for major TCR expansions in healthy adults caused by persistent Epstein-Barr virus infection [J].
Silins, SL ;
Cross, SM ;
Krauer, KG ;
Moss, DJ ;
Schmidt, CW ;
Misko, IS .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (08) :1551-1558